Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Sale of product	$ 2,159,559	$ 2,135,839	$ 4,495,345	$ 4,663,691
Cost of product	903,909	971,384	1,872,434	2,059,812
Gross profit	1,255,650	1,164,455	2,622,911	2,603,879
Operating costs and expenses:
Salaries and contract labor	736,539	596,045	1,477,744	1,219,744
General, administrative and consulting	573,747	600,580	1,362,185	1,227,443
Research and development	41,465	50,354	88,393	96,658
Total operating expenses	1,351,751	1,246,979	2,928,322	2,543,845
Net operating (loss) income	(96,101)	(82,524)	(305,411)	60,034
Other income (expense):
Other income	559,895	(867,660)	583,713	(843,028)
Interest income	748	3,611	3,083	7,033
Interest expense	(196,344)	(136,842)	(391,224)	(250,919)
Total other income (expense)	364,299	(1,000,891)	195,572	(1,086,914)
Net (loss) income	268,198	(1,083,415)	(109,839)	(1,026,880)
Less income attributable to non-controlling interest	38,870	73,779	83,327	182,271
Net income (loss) attributable to International Isotopes Inc.	$ 229,328	$ (1,157,194)	$ (193,166)	$ (1,209,151)
Net income (loss) per common share - basic
Net income (loss) per common share - diluted
Weighted average common shares outstanding - basic	423,751,657	419,230,535	422,211,840	416,568,617
Weighted average common shares outstanding - diluted	432,629,537	419,230,535	422,211,840	416,568,617